Penn Trials Shine New Light on Advanced Melanoma Treatment

October 17, 2011


The statistics on melanoma are staggering: it’s one of the fastest growing cancers in the United States and around the world, and the top cause of deaths related to skin cancer in this country.  The American Cancer Center estimates that more than 68,000 people were diagnosed with melanoma last year; 8,700 died from the disease.

Fortunately, there is new hope for patients with melanoma.

For the first time after a drought spanning 10 years, the FDA approved a new drug treatment for advanced melanoma -- Yervoy, a drug that stimulates the immune system to attack tumors. Additionally, several clinical trials using new agents that target a specific genetic mutation carried by some melanomas yielded unprecedented results in extending overall survival and improving quality of life in patients with advanced melanoma... Read More

Related Information